Variant report

Variant	nsv980702
Chromosome Location	chr5:98015320-98017447
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 88 )
Associated
traits (count: 82 )

Variant overlapped rSNPs/rCNVs (count:88 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs537146191	chr5:98015325-98015326	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs555210983	chr5:98015391-98015392	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs573561977	chr5:98015421-98015422	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs76663763	chr5:98015458-98015459	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs200319761	chr5:98015472-98015473	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs559584442	chr5:98015500-98015501	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs573210737	chr5:98015523-98015524	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs545252599	chr5:98015528-98015529	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs545154493	chr5:98015562-98015563	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs563539848	chr5:98015588-98015589	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs142928571	chr5:98015595-98015596	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs549442223	chr5:98015646-98015647	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs192242833	chr5:98015663-98015664	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs10479227	chr5:98015723-98015724	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs10479228	chr5:98015731-98015732	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs565937547	chr5:98015756-98015757	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs539748074	chr5:98015794-98015795	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs565160759	chr5:98015805-98015806	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs551747003	chr5:98015815-98015816	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs184306585	chr5:98015816-98015817	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs536881789	chr5:98015818-98015819	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs555413945	chr5:98015835-98015836	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs573671116	chr5:98015843-98015844	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs189517503	chr5:98015847-98015848	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs374257288	chr5:98015896-98015897	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs552552609	chr5:98015900-98015901	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs577268842	chr5:98015903-98015904	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs545289737	chr5:98015950-98015951	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs114782896	chr5:98015993-98015994	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs575775084	chr5:98016002-98016003	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs542871639	chr5:98016026-98016027	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs10479229	chr5:98016033-98016034	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs112318278	chr5:98016050-98016051	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs546966691	chr5:98016069-98016070	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs181739713	chr5:98016098-98016099	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs532590853	chr5:98016107-98016108	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs551685169	chr5:98016110-98016111	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs6877710	chr5:98016115-98016116	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs537216500	chr5:98016134-98016135	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs17729817	chr5:98016158-98016159	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs567307789	chr5:98016172-98016173	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs534412759	chr5:98016221-98016222	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs6861926	chr5:98016245-98016246	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs570896388	chr5:98016249-98016250	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs372900574	chr5:98016252-98016253	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs149782121	chr5:98016253-98016254	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs538277625	chr5:98016281-98016282	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs160710	chr5:98016333-98016334	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs575862978	chr5:98016352-98016353	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs376653658	chr5:98016381-98016382	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:82)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
Non-small cell lung cancer	21829676	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Lung cancer	18438408	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Merkel cell carcinoma	19020549	CNVD
Squamous cell cancer	20885788	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute myeloid leukemia	21251322	CNVD
lymphocytic leukemia	21291569	CNVD
Testicular cancer	18059402	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	17053054	CNVD
Renal cell carcinoma	18194544	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Cancer	20164920	CNVD
Myelodysplastic syndrome	21251322	CNVD
abnormal development	18461090	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	16774939	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Multiple myeloma	17550852	CNVD
Glioblastoma multiforme	22286061	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Breast cancer	21611746	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:10 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:98015000-98016200	Enhancers	Dnd41	blood
2	chr5:98015200-98015800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
3	chr5:98015200-98016400	Enhancers	Muscle Satellite Cultured Cells	--
4	chr5:98015200-98016600	Enhancers	HSMM	muscle
5	chr5:98015400-98016400	Enhancers	NH-A	brain
6	chr5:98015600-98017000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
7	chr5:98015800-98016200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr5:98015800-98016400	Enhancers	HSMMtube	muscle
9	chr5:98016000-98016800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
10	chr5:98016200-98026000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links